Fate Therapeutics Inc. (FATE)
Market Closed
17 Jul, 20:00
$
2. 78
+0.05
+1.8315%
$
348.51M Market Cap
- P/E Ratio
- Div Yield
1.69M Volume
-1.96 Eps
$ 2.73
Previous Close 
Want to track FATE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Fate Therapeutics Inc. (FATE) Statistics
Valuation metrics
Market Cap 348.51M
Enterprise value 361.25M
Trailing P/E (ttm) -2.55
Forward P/E -
PEG ratio -0.08
Price/Sales (ttm) 51.3
Price/Book (mrq) 1.86
Enterprise Value/Revenue 57.2
Enterprise Value/EBITDA -3.08
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.69M
Average volume (90 days) 4.01M
Price summary
52-Week low 0.91
52-Week high 3.23
Beta -
50-Day moving average 2.34
200-Day moving average 1.42
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -20.57%
Operating margin -22.07%
Operational effectiveness
Return on assets -0.46%
Return on equity -0.59%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.46
Total debt (mrq) -
Total Debt/Equity (mrq) 0.43
Current ratio (mrq) 5.85%
Book value per share (mrq) 1.5
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
